Empagliflozin vs Pembrolizumab

## Empagliflozin vs Pembrolizumab: Overview

This comparison examines the pharmacological differences between **Empagliflozin** and **Pembrolizumab**.

## Mechanism of Action

**Empagliflozin**: Selective SGLT2 inhibitor reducing renal glucose reabsorption.

**Pembrolizumab**: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

## Pharmacokinetics

**Half-life**: Empagliflozin — 12.4 hours; Pembrolizumab — 26 days.

## Chemical Properties

**Molecular Formula**: Empagliflozin — C23H27ClO7; Pembrolizumab — N/A.

**Molecular Weight**: Empagliflozin — 450.9100 g/mol; Pembrolizumab — N/A.

**Type**: Empagliflozin — Small molecule; Pembrolizumab — Antibody.